The rational design and evaluation of a peptide inhibitor of the PD-1/PD-L1 interaction

被引：0
|
作者：
Boohaker, Rebecca J. [1 ]
Sambandam, Vijaya [1 ]
Suto, Mark [1 ]
Xu, Bo [1 ]
机构：
[1] Southern Res Inst, Birmingham, AL 35255 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-5668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5668
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Small molecule PD-L1 inhibitor modulates expression of PD-L1 on the cell surface - a potential mechanism of blocking interaction with PD-1
    Weitsman, G.
    Chan, J. Nuo En
    Nedbal, J.
    Barber, P. R.
    Volgina, A.
    Stevens, C.
    Poland, S.
    Ameer-Beg, S.
    Suhling, K.
    Rios-Doria, J.
    Ng, T.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S70 - S70
  • [32] Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy
    Chang, Hao-Nan
    Liu, Bei-Yuan
    Qi, Yun-Kun
    Zhou, Yang
    Chen, Yan-Ping
    Pan, Kai-Mai
    Li, Wen-Wen
    Zhou, Xiu-Man
    Ma, Wei-Wei
    Fu, Cai-Yun
    Qi, Yuan-Ming
    Liu, Lei
    Gao, Yan-Feng
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (40) : 11760 - 11764
  • [33] Small-molecule inhibitor PD-1 /PD-L1 interaction for colorectal cancer treatment
    Anaya-Ruiz, Maricruz
    Perez-Santos, Martin
    PHARMACEUTICAL PATENT ANALYST, 2021, 10 (06) : 245 - 250
  • [34] PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
    Katerina Ancevski Hunter
    Mark A. Socinski
    Liza C. Villaruz
    Molecular Diagnosis & Therapy, 2018, 22 : 1 - 10
  • [35] Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1)
    Wen, Biyan
    Zhao, Lin
    Wang, Yuchu
    Qiu, Chuangnan
    Xu, Zhimin
    Huang, Kunling
    Zhu, He
    Li, Zemin
    Li, Huangjin
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2020, 50 (03): : 252 - 259
  • [36] From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
    Zhao, Xuan
    Bao, Yulin
    Meng, Bi
    Xu, Zijian
    Li, Sijin
    Wang, Xu
    Hou, Rui
    Ma, Wen
    Liu, Dan
    Zheng, Junnian
    Shi, Ming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Bis(benzonitrile) dichloroplatinum (II) interrupts PD-1/PD-L1 interaction by binding to PD-1
    Wang, Rui-na
    Yu, Qian
    Wang, Xiao-bo
    Zhu, Di
    Li, Guo-long
    Li, Zeng-xia
    Jiang, Wei
    Li, Wei
    Dang, Yong-jun
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (10) : 2103 - 2112
  • [38] PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
    Hunter, Katerina Ancevski
    Socinski, Mark A.
    Villaruz, Liza C.
    MOLECULAR DIAGNOSIS & THERAPY, 2018, 22 (01) : 1 - 10
  • [39] Bis(benzonitrile) dichloroplatinum (II) interrupts PD-1/PD-L1 interaction by binding to PD-1
    Rui-na Wang
    Qian Yu
    Xiao-bo Wang
    Di Zhu
    Guo-long Li
    Zeng-xia Li
    Wei Jiang
    Wei Li
    Yong-jun Dang
    Acta Pharmacologica Sinica, 2023, 44 : 2103 - 2112
  • [40] Design, Synthesis, and Evaluation of PD-1/PD-L1 Antagonists Bearing a Benzamide Scaffold
    Lu, Lu
    Qi, Zhihao
    Wang, Tianyu
    Zhang, Xiangyu
    Zhang, Kuojun
    Wang, Kaizhen
    Cheng, Yao
    Xiao, Yibei
    Li, Zheng
    Jiang, Sheng
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (04): : 586 - 592
12345